How to Know If You Have Heart Disease: Symptoms & Tests

Heart disease often announces itself through symptoms you can feel, but it can also develop silently for years before anything seems wrong. Recognizing the warning signs and understanding which tests can catch problems early are two separate skills, and both matter. The tricky part is that the “classic” heart attack presentation everyone pictures, crushing chest pain radiating down the left arm, accounts for only a portion of cases, and some of the most reliable diagnostic tools are ones your doctor has to specifically order rather than tests that happen automatically at a checkup.

What Heart Disease Symptoms Actually Feel Like

The textbook symptom of coronary artery disease is angina: chest discomfort that tends to come on with exertion or emotional stress and eases with rest. It often feels like pressure, squeezing, or heaviness behind the breastbone, and it can spread to the jaw, neck, shoulders, or arms. In a study of patients evaluated for coronary artery disease, those with these “typical” angina features were roughly two and a half times more likely to have significant blockages than patients with vague or non-chest-pain symptoms, even after accounting for other risk factors.​1PubMed. The importance of characteristics of angina symptoms for the prediction of coronary artery disease in a cohort of stable patients in the modern era That said, plenty of people with real heart disease never experience that classic pattern.

Shortness of breath that comes on with ordinary activities you used to handle easily is one of the most overlooked cardiac symptoms. Fatigue that seems disproportionate to what you’re doing, unexplained nausea, dizziness, or a cold sweat can all signal that the heart muscle isn’t getting enough blood. Heart failure, a condition where the heart’s pumping ability weakens, tends to show up as ankle swelling, trouble breathing when lying flat, and persistent tiredness. And arrhythmias, or irregular heart rhythms, often feel like fluttering, skipped beats, or a sudden pounding sensation in the chest.

Why Symptoms Differ Between Women and Men

One of the most important and still under-recognized realities about heart disease is that women tend to present differently than men. A study of patients arriving at a hospital with heart attacks found that about 85% of women showed up with atypical symptoms like dizziness, sweating, shortness of breath, vomiting, palpitations, back pain, and fatigue, compared with about 70% of men.​2PubMed Central. Atypical Manifestations of Women Presenting with Myocardial Infarction at Tertiary Health Care Center: An Analytical Study Women also described their chest pain differently, more often as squeezing or tightness rather than the burning or pricking sensations men reported.

A review comparing heart attack presentations across sexes confirmed that while chest, arm, and jaw pain remained common in both groups, women on average had more nausea, vomiting, and shortness of breath. Women were also more likely to report prodromal symptoms, unusual fatigue in the days leading up to the event, and they took longer to get to the hospital after symptoms began.​3PubMed Central. Myocardial Infarction Signs and Symptoms: Females vs. Males The core chest pain itself is largely similar in both sexes, but the additional non-chest symptoms can delay diagnosis in women, partly because patients and clinicians alike may not immediately connect them to the heart.​4PubMed Central. Chest Pain in Women: Gender- and Sex-based Differences in the Presentation and Diagnosis of Heart Disease

Men, interestingly, are more likely to have a “silent” or unrecognized heart attack, one that shows up on a later ECG or imaging study without ever having produced symptoms the person noticed at the time.​3PubMed Central. Myocardial Infarction Signs and Symptoms: Females vs. Males So neither sex has a monopoly on missed diagnoses; they just miss them in different ways.

When Heart Disease Produces No Symptoms at All

Silent heart disease is more common than most people realize, and certain groups are especially vulnerable. People with diabetes stand out. Nerve damage from diabetes can blunt the chest pain that would otherwise serve as an alarm. A study of men with diabetes who had no cardiac complaints found silent ischemia, reduced blood flow to the heart without symptoms, in about 17% of them. Among those who also had autonomic nerve dysfunction, the rate jumped to 38%.​5The American Journal of Cardiology. Detection of silent myocardial ischemia in diabetes mellitus The implication is straightforward: if you have diabetes, the absence of chest pain does not mean your coronary arteries are fine.

Older adults, people with kidney disease, and those on certain medications that dull pain perception can also develop significant coronary artery disease without obvious symptoms. This is exactly why screening tests and risk calculators exist, to catch problems in people who feel perfectly well.

Blood Tests That Help Spot Heart Trouble

Blood work cannot tell you whether you have clogged arteries the way an imaging test can, but several markers give clinicians important puzzle pieces.

Troponin for Acute Heart Damage

When heart muscle cells are injured, they release a protein called troponin into the bloodstream. Modern high-sensitivity troponin assays can detect very low levels and improve overall diagnostic accuracy in patients with suspected heart attacks. A negative result has strong predictive value for ruling out an acute event.​6PubMed Central. High-sensitive cardiac troponin T Doctors typically check troponin levels twice, a few hours apart, because the change over time helps distinguish a new heart attack from chronic low-level injury caused by other conditions like heart failure or kidney disease.​7PubMed. High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain The trade-off with these ultra-sensitive assays is that they sometimes pick up tiny elevations from causes that aren’t heart attacks, so interpreting the result always depends on the full clinical picture.

Cholesterol and Inflammation Markers for Long-Term Risk

A standard lipid panel, measuring total cholesterol, LDL, HDL, and triglycerides, remains a cornerstone of cardiovascular risk assessment. But the ratio of total cholesterol to HDL cholesterol turns out to be at least as useful as more exotic markers for predicting events.​8JAMA. Non–HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women Adding a high-sensitivity C-reactive protein (hs-CRP) test, a marker of inflammation, improves prediction beyond lipids alone. In a large study of women, those in the highest hs-CRP quartile had more than four times the cardiovascular event rate of those in the lowest quartile, and hs-CRP predicted risk even among women whose LDL cholesterol was below guideline targets.​9PubMed. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

More recent work has explored combining hs-CRP with HDL cholesterol into a single ratio. A large cohort study found that a higher hs-CRP-to-HDL ratio was an independent contributor to cardiovascular disease risk, and the association was stronger in younger participants.​10PubMed Central. The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people None of these blood tests diagnose blockages directly, but they help your doctor decide whether you need further testing or more aggressive prevention.

BNP for Heart Failure

If the concern is heart failure rather than coronary blockages, a different blood test takes center stage: B-type natriuretic peptide, or BNP. The heart releases BNP when its walls are stretched from overwork. In patients showing up with unexplained shortness of breath, a BNP level above about 80 to 100 pg/mL is a strong signal of heart failure, and combining it with an echocardiogram dramatically improves diagnostic accuracy. One study found that BNP alone correctly classified about two-thirds of patients, the echocardiogram alone about 55%, but together, with basic clinical data, accuracy climbed above 97%.​11PubMed. B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea Because the test is a simple blood draw, it can also serve as a cost-effective first screening step, sparing patients who clearly don’t have heart failure from an unnecessary echocardiogram.​12Clinical Chemistry. Rapid Brain Natriuretic Peptide Test and Doppler Echocardiography for Early Diagnosis of Mild Heart Failure

Stress Tests and What They Can and Cannot Tell You

A stress test pushes the heart to work harder, usually through exercise on a treadmill or stationary bike, and watches for signs that blood flow can’t keep up with demand. The simplest version tracks your ECG during exercise. A meta-analysis of stress-test studies found that a treadmill ECG has a positive likelihood ratio of about 3.6 for detecting coronary artery disease, meaning an abnormal result roughly triples the odds you have significant blockages.​13PubMed. Diagnostic accuracy of exercise stress testing for coronary artery disease: a systematic review and meta-analysis of prospective studies That’s useful but far from definitive. Adding ultrasound imaging of the heart during the test, a stress echocardiogram, roughly doubles the diagnostic power, with a likelihood ratio over 7 for ruling in disease.

A common frustration with the basic treadmill ECG is its relatively low specificity. The ST-segment changes on the ECG that suggest ischemia can also appear in people without significant blockages, particularly in women, leading to false-positive results that trigger unnecessary downstream testing.​14Barind Medical College Journal. Study of QT dispersion after exercise stress test improves sensitivity and specificity for diagnosis of coronary artery disease If you can’t exercise because of joint problems or other limitations, pharmacologic stress tests use medications to mimic the effect of exercise on the heart.

Imaging Without a Catheter

When a stress test is inconclusive or your risk profile warrants a closer look, several imaging options can visualize the heart and its arteries without threading a catheter into your body.

Coronary Artery Calcium Scoring

A coronary artery calcium (CAC) scan uses a quick, low-dose CT to measure calcified plaque in your coronary arteries. It’s most useful for people whose risk falls in the intermediate zone, where the decision about whether to start a statin or aspirin is genuinely uncertain. A large study found that adding the calcium score to traditional risk factors reclassified about 23% more people who eventually had events into the high-risk category and moved about 13% of event-free people down to low risk.​15JAMA. Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction A score above 300 was associated with a significant jump in coronary events beyond what standard risk factors predicted.​16JAMA. Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals

A score of zero is highly reassuring for ruling out significant plaque, but it’s not a permanent all-clear. Current guidance suggests reassessment every five to ten years because calcium can accumulate over time.​17PubMed Central. Computed tomography and coronary artery calcium score for screening of coronary artery disease and cardiovascular risk management in asymptomatic individuals The scan doesn’t detect soft, non-calcified plaque, so a zero score in a young smoker with terrible lipids doesn’t mean the arteries are in great shape.

CT Coronary Angiography

CT coronary angiography (CCTA) goes further than a calcium scan by using contrast dye to produce detailed 3D images of the coronary arteries. Data from large trials show that CCTA is highly sensitive for detecting coronary artery disease, can identify high-risk plaque that functional stress tests would miss, and provides enough diagnostic certainty to guide treatment decisions, including whether to proceed to an invasive catheterization.​18PubMed. PROMISE of Coronary CT Angiography: Precise and Accurate Diagnosis and Prognosis in Coronary Artery Disease It’s increasingly used as a first-line test for stable chest pain in many guidelines.

Nuclear Perfusion and Stress Echocardiography

Nuclear myocardial perfusion imaging uses a small amount of radioactive tracer to map blood flow through the heart muscle at rest and under stress. While stress echocardiography can detect coronary disease comparably, nuclear perfusion tends to detect more at-risk heart muscle and consequently identifies more patients vulnerable to future cardiac events.​19PubMed. Stress nuclear myocardial perfusion imaging versus stress echocardiography: prognostic comparisons The choice between these tests often depends on local expertise, your body type, and what information your doctor needs most.

When the Catheter Comes Out

Invasive coronary angiography, where a thin tube is threaded through a wrist or groin artery into the coronary arteries, remains the gold standard for visualizing blockages. If a blockage looks moderate on the angiogram and the doctor isn’t sure whether it’s actually restricting blood flow, fractional flow reserve (FFR) measurement can settle the question. A tiny pressure sensor on a wire measures the pressure drop across the narrowing while the artery is maximally dilated. FFR has been shown to be a reliable substitute for non-invasive stress testing in gauging whether a blockage needs treatment.​20PubMed. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial Newer software can even estimate FFR from the angiogram images alone, reducing the need for extra wires and medications during the procedure.​21PubMed. Accuracy of Fractional Flow Reserve Derived From Coronary Angiography

When Arteries Look Clear but the Heart Still Hurts

One of the most frustrating experiences for patients is going through a catheterization, being told their arteries look fine, and still having chest pain. This scenario has a name: INOCA, which stands for ischemia with no obstructive coronary artery disease. It’s not rare, and it disproportionately affects women. An American College of Cardiology working group identified that a subgroup of these patients has dysfunction in the tiny blood vessels of the heart, called coronary microvascular dysfunction, along with evidence of inflammation.​22PubMed Central. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade

Diagnosing INOCA requires specialized tests that go beyond standard angiography. Doctors can measure coronary flow reserve and microvascular resistance using pressure and flow wires, or provoke spasm with acetylcholine injections during catheterization.​23PubMed. Ischemia with No Obstructive Arteries (INOCA): A Review of the Prevalence, Diagnosis and Management These tests aren’t available everywhere, but awareness is growing. If you’ve been told your arteries are clear yet your symptoms persist, asking about INOCA testing is reasonable.

Chest Pain That Isn’t the Heart

Not every chest pain comes from the heart, and after cardiac causes have been excluded, the most common culprits are gastrointestinal. Acid reflux is the leading cause of noncardiac chest pain, and the burning or pressure it produces can feel disturbingly similar to angina. Esophageal spasm and heightened sensitivity of the esophageal nerves account for additional cases. Psychological conditions like panic disorder, anxiety, and depression are also common in people with noncardiac chest pain and can amplify how severe the discomfort feels.​24PubMed Central. Noncardiac chest pain: epidemiology, natural course and pathogenesis Getting a clear cardiac workup is important precisely because it opens the door to treating these other causes, many of which respond well to targeted therapy.

Wearable Devices and Heart Rhythm Monitoring

Smartwatches have added a new layer to heart disease detection, particularly for irregular rhythms like atrial fibrillation. The evidence here is mixed but improving. A meta-analysis pooling eleven studies on the Apple Watch ECG app found a pooled sensitivity of about 79% and a specificity of about 91% for detecting atrial fibrillation.​25npj Digital Medicine. The accuracy of Apple Watch measurements: a living systematic review and meta-analysis When the watch delivers a clear reading, the accuracy is high. The catch is that roughly 15 to 25% of readings are classified as inconclusive, and the passive notification feature that monitors your pulse in the background has much lower sensitivity, around 21% in one study, meaning it misses most episodes even though it almost never raises a false alarm.​26European Heart Journal. Accuracy of the Apple Watch in detecting atrial fibrillation among patients undergoing 24-hour Holter monitoring

The practical takeaway: a smartwatch can capture diagnostic-quality rhythm strips that are genuinely useful when you feel palpitations, and a confirmed atrial fibrillation reading should be taken seriously.​27PubMed. Smartwatch-based detection of cardiac arrhythmias: Beyond the differentiation between sinus rhythm and atrial fibrillation But the absence of an alert on your wrist does not rule out arrhythmia. If you have symptoms like repeated palpitations, light-headedness, or unexplained fainting, a medical-grade Holter monitor or an implantable loop recorder is still the standard way to catch intermittent rhythms.

Risk Calculators and Their Limits

Before ordering any test, most doctors start with a risk calculator. The Pooled Cohort Equations (PCE), used in U.S. guidelines since 2013, estimate your ten-year probability of a heart attack or stroke based on age, sex, race, blood pressure, cholesterol, diabetes status, and smoking. The newer PREVENT equations expand on this by incorporating kidney function and other factors. In head-to-head comparison, both models show moderate ability to distinguish who will and won’t have an event, but the PCE tends to overestimate risk, sometimes by roughly double the actual event rate observed in large real-world populations.​28PubMed Central. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Real-World Population​29PubMed Central. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction

That overestimation matters because it can push people toward medications or invasive tests they might not need. It’s one reason the calcium score has gained traction as a tie-breaker: if the calculator says you’re intermediate risk but your calcium score is zero, most guidelines would support holding off on a statin and rechecking in several years.

Detecting Valve Disease Before It’s Too Late

Heart disease isn’t limited to clogged arteries. Diseased heart valves, whether leaky or too narrow, can quietly damage the heart muscle before symptoms become obvious. Most patients with significant valve disease present late because their symptoms, typically breathlessness and fatigue, get attributed to aging or deconditioning. Listening with a stethoscope has limited sensitivity for picking up valve problems, and handheld ultrasound devices used in primary care settings show promise for improving detection rates, though evidence on clinical outcomes is still needed.​30PubMed Central. Detecting heart valve disease: can we do better? If you’re over 65 and notice that you’re getting winded more easily or feeling lightheaded during activity, asking your doctor to listen specifically for a heart murmur, and possibly requesting an echocardiogram if one is heard, is a reasonable step.